by Mike Masnick
Mon, Dec 20th 2010 1:57pm
Last year, we wrote how a bunch of doctors were quite worried about an ongoing patent lawsuit, Prometheus Laboratories v. Mayo Collaborative Services. It involved a company, Prometheus, that claimed it could patent basic medial diagnostics, and basically said no one (such as the Mayo Clinic) could diagnose patients in the same way without paying Prometheus. The whole concept was abhorrent to many doctors. Yet, as we worried, last year the appeals court (CAFC), as it has done so often, sided with the patent holders. This summer, when the Supreme Court decided Bilski, one thing it asked CAFC to do was reconsider the Prometheus case. It's now done so, and nothing much has changed. Once again, CAFC has said that basic diagnostic tests may be patentable. Many also think (probably correctly) that this is a good indication that CAFC will also reverse a lower court ruling in the Myriad Genetics case, concerning whether or not genes are patentable. If diagnostic tests are patentable, why not genes? Of course, all this really means is that sooner or later the Supreme Court is going to have to weigh in again, and hopefully it won't punt the issue like it did in Bilski.
If you liked this post, you may also be interested in...
- Intellectual Ventures Big Case Shut Down By Judge Over Completely Bogus Patents
- Supreme Court Discussion In Aereo: At Least The Justices Recognize The Harm They Might Do
- Revolving Door: MPAA Hires Chief USTR Negotiator Behind ACTA And TPP's IP Chapter
- Myriad Genetics Loses Again: Court Refuses To Grant Preliminary Injunction Against Rival Genetic Testing Company
- US Court Rules Again That Natural Phenomena Cannot Be Patented, Casting Further Doubt On Gene Patents